|
OSBPL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.363970E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.430500E-04 |
| Normal-vs-Stage2 |
2.548300E-02 |
| Normal-vs-Stage3 |
1.580260E-02 |
| Normal-vs-Stage4 |
1.62124999999458E-05 |
| Stage1-vs-Stage2 |
6.030400E-01 |
| Stage1-vs-Stage3 |
5.693800E-01 |
| Stage1-vs-Stage4 |
3.043000E-03 |
| Stage2-vs-Stage3 |
9.929600E-01 |
| Stage2-vs-Stage4 |
8.520400E-02 |
| Stage3-vs-Stage4 |
6.477700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.340700E-03 |
| Normal-vs-AfricanAmerican |
4.022600E-03 |
| Normal-vs-Asian |
2.061800E-02 |
| Caucasian-vs-AfricanAmerican |
6.595600E-01 |
| Caucasian-vs-Asian |
5.659400E-01 |
| AfricanAmerican-vs-Asian |
5.707200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.648500E-04 |
| Normal-vs-Female |
4.526300E-02 |
| Male-vs-Female |
3.284800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.188400E-04 |
| Normal-vs-Extreme_Weight |
1.405570E-04 |
| Normal-vs-Obese |
6.153500E-02 |
| Normal-vs-Extreme_Obese |
5.624500E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.628800E-01 |
| Normal_Weight-vs-Obese |
1.301970E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.293600E-01 |
| Extreme_Weight-vs-Obese |
9.133700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.731800E-01 |
| Obese-vs-Extreme_Obese |
2.877200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.887600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.466400E-02 |
| Normal-vs-Age(61-80Yrs) |
4.960300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.82234999999142E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.151200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.817200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.415860E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.224560E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.279670E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.601900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.454100E-02 |
| Normal-VS-Type2 PRCC |
8.46059999837223E-09 |
| Normal-VS-KIRP CIMP |
4.684000E-03 |
| Normal-VS-Unclassified PRCC |
3.381800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.26310000026342E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.775360E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.538200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.465400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.321710E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
9.510400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.8140999999724E-06 |
| Normal-vs-N1 |
7.201500E-04 |
| Normal-vs-N2 |
6.834000E-04 |
| N0-vs-N1 |
5.102400E-01 |
| N0-vs-N2 |
1.921630E-01 |
| N1-vs-N2 |
9.154400E-02 |
|
|
